Peter Sleight
Peter Sleight (27 August 1929 – 7 October 2020) was a renowned British cardiologist and academic. He made significant contributions to the field of cardiology, particularly in the areas of hypertension, heart rate variability, and the role of the autonomic nervous system in cardiovascular disease.
Early Life and Education[edit | edit source]
Peter Sleight was born on 27 August 1929. He pursued his medical education at Oxford University, where he developed an interest in cardiology. He completed his clinical training at St Thomas' Hospital in London.
Career[edit | edit source]
Sleight's career in cardiology began at Oxford University, where he worked as a research fellow. He later became a professor of cardiovascular medicine at the University of Oxford. Throughout his career, he was associated with several prestigious institutions, including the John Radcliffe Hospital.
Research Contributions[edit | edit source]
Peter Sleight's research focused on the mechanisms of hypertension and the role of the autonomic nervous system in cardiovascular disease. He was instrumental in the development of ambulatory blood pressure monitoring and contributed to the understanding of heart rate variability as a predictor of cardiovascular events.
Clinical Trials[edit | edit source]
Sleight was involved in several landmark clinical trials, including the European Society of Cardiology's HOPE study (Heart Outcomes Prevention Evaluation), which investigated the effects of ramipril on cardiovascular events in high-risk patients. His work in these trials has had a lasting impact on the management of cardiovascular disease.
Awards and Honors[edit | edit source]
Peter Sleight received numerous awards and honors throughout his career. He was a fellow of the Royal College of Physicians and received the Gold Medal from the European Society of Cardiology for his contributions to the field.
Personal Life[edit | edit source]
Peter Sleight was married and had children. He passed away on 7 October 2020, leaving behind a legacy of significant contributions to the field of cardiology.
See Also[edit | edit source]
- Cardiology
- Hypertension
- Heart rate variability
- Autonomic nervous system
- Cardiovascular disease
- University of Oxford
- John Radcliffe Hospital
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD